Report Detail
Global Phospholipids in Pharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4519966 |
- 14 March, 2023 |
- Global |
- 90 Pages |
- GIR (Global Info Research) |
- Chemical & Material
According to our (Global Info Research) latest study, the global Phospholipids in Pharmaceutical market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In pharmaceutical formulations, phospholipids obtained from plant or animal sources and synthetic phospholipids are used. Natural phospholipids are purified from, e.g., soybeans or egg yolk using non-toxic solvent extraction and chromatographic procedures with low consumption of energy and minimum possible waste. Because of the use of validated purification procedures and sourcing of raw materials with consistent quality, the resulting products differing in phosphatidylcholine content possess an excellent batch to batch reproducibility with respect to phospholipid and fatty acid composition. The natural phospholipids are described in pharmacopeias and relevant regulatory guidance documentation of the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Synthetic phospholipids with specific polar head group, fatty acid composition can be manufactured using various synthesis routes. Synthetic phospholipids with the natural stereochemical configuration are preferably synthesized from glycerophosphocholine (GPC), which is obtained from natural phospholipids, using acylation and enzyme catalyzed reactions. Synthetic phospholipids play compared to natural phospholipid (including hydrogenated phospholipids), as derived from the number of drug products containing synthetic phospholipids, a minor role. Only in a few pharmaceutical products synthetic phospholipids are used. Natural phospholipids are used in oral, dermal, and parenteral products including liposomes. Natural phospholipids instead of synthetic phospholipids should be selected as phospholipid excipients for formulation development, whenever possible, because natural phospholipids are derived from renewable sources and produced with more ecologically friendly processes and are available in larger scale at relatively low costs compared to synthetic phospholipids.
This report is a detailed and comprehensive analysis for global Phospholipids in Pharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Source and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Phospholipids in Pharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Phospholipids in Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Phospholipids in Pharmaceutical market size and forecasts, by Source and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Phospholipids in Pharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phospholipids in Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phospholipids in Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cargill, Avril, Croda, Lipoid and Nippon Fine Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Phospholipids in Pharmaceutical market is split by Source and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Source, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Source
Soy
Egg
Synthetic
Others
Market segment by Application
Oral Products
Dermal Products
Parenteral Products
Others
Major players covered
Cargill
Avril
Croda
Lipoid
Nippon Fine Chemical
Sonic Biochem
Nabros Pharma
Vav
NOF
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Phospholipids in Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Phospholipids in Pharmaceutical, with price, sales, revenue and global market share of Phospholipids in Pharmaceutical from 2018 to 2023.
Chapter 3, the Phospholipids in Pharmaceutical competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Phospholipids in Pharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Source and application, with sales market share and growth rate by source, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Phospholipids in Pharmaceutical market forecast, by regions, source and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Phospholipids in Pharmaceutical.
Chapter 14 and 15, to describe Phospholipids in Pharmaceutical sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Phospholipids in Pharmaceutical
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Source
- 1.3.1 Overview: Global Phospholipids in Pharmaceutical Consumption Value by Source: 2018 Versus 2022 Versus 2029
- 1.3.2 Soy
- 1.3.3 Egg
- 1.3.4 Synthetic
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Phospholipids in Pharmaceutical Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Oral Products
- 1.4.3 Dermal Products
- 1.4.4 Parenteral Products
- 1.4.5 Others
- 1.5 Global Phospholipids in Pharmaceutical Market Size & Forecast
- 1.5.1 Global Phospholipids in Pharmaceutical Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Phospholipids in Pharmaceutical Sales Quantity (2018-2029)
- 1.5.3 Global Phospholipids in Pharmaceutical Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Cargill
- 2.1.1 Cargill Details
- 2.1.2 Cargill Major Business
- 2.1.3 Cargill Phospholipids in Pharmaceutical Product and Services
- 2.1.4 Cargill Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Cargill Recent Developments/Updates
- 2.2 Avril
- 2.2.1 Avril Details
- 2.2.2 Avril Major Business
- 2.2.3 Avril Phospholipids in Pharmaceutical Product and Services
- 2.2.4 Avril Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Avril Recent Developments/Updates
- 2.3 Croda
- 2.3.1 Croda Details
- 2.3.2 Croda Major Business
- 2.3.3 Croda Phospholipids in Pharmaceutical Product and Services
- 2.3.4 Croda Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Croda Recent Developments/Updates
- 2.4 Lipoid
- 2.4.1 Lipoid Details
- 2.4.2 Lipoid Major Business
- 2.4.3 Lipoid Phospholipids in Pharmaceutical Product and Services
- 2.4.4 Lipoid Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Lipoid Recent Developments/Updates
- 2.5 Nippon Fine Chemical
- 2.5.1 Nippon Fine Chemical Details
- 2.5.2 Nippon Fine Chemical Major Business
- 2.5.3 Nippon Fine Chemical Phospholipids in Pharmaceutical Product and Services
- 2.5.4 Nippon Fine Chemical Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Nippon Fine Chemical Recent Developments/Updates
- 2.6 Sonic Biochem
- 2.6.1 Sonic Biochem Details
- 2.6.2 Sonic Biochem Major Business
- 2.6.3 Sonic Biochem Phospholipids in Pharmaceutical Product and Services
- 2.6.4 Sonic Biochem Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Sonic Biochem Recent Developments/Updates
- 2.7 Nabros Pharma
- 2.7.1 Nabros Pharma Details
- 2.7.2 Nabros Pharma Major Business
- 2.7.3 Nabros Pharma Phospholipids in Pharmaceutical Product and Services
- 2.7.4 Nabros Pharma Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Nabros Pharma Recent Developments/Updates
- 2.8 Vav
- 2.8.1 Vav Details
- 2.8.2 Vav Major Business
- 2.8.3 Vav Phospholipids in Pharmaceutical Product and Services
- 2.8.4 Vav Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Vav Recent Developments/Updates
- 2.9 NOF
- 2.9.1 NOF Details
- 2.9.2 NOF Major Business
- 2.9.3 NOF Phospholipids in Pharmaceutical Product and Services
- 2.9.4 NOF Phospholipids in Pharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 NOF Recent Developments/Updates
3 Competitive Environment: Phospholipids in Pharmaceutical by Manufacturer
- 3.1 Global Phospholipids in Pharmaceutical Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Phospholipids in Pharmaceutical Revenue by Manufacturer (2018-2023)
- 3.3 Global Phospholipids in Pharmaceutical Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Phospholipids in Pharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Phospholipids in Pharmaceutical Manufacturer Market Share in 2022
- 3.4.2 Top 6 Phospholipids in Pharmaceutical Manufacturer Market Share in 2022
- 3.5 Phospholipids in Pharmaceutical Market: Overall Company Footprint Analysis
- 3.5.1 Phospholipids in Pharmaceutical Market: Region Footprint
- 3.5.2 Phospholipids in Pharmaceutical Market: Company Product Type Footprint
- 3.5.3 Phospholipids in Pharmaceutical Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Phospholipids in Pharmaceutical Market Size by Region
- 4.1.1 Global Phospholipids in Pharmaceutical Sales Quantity by Region (2018-2029)
- 4.1.2 Global Phospholipids in Pharmaceutical Consumption Value by Region (2018-2029)
- 4.1.3 Global Phospholipids in Pharmaceutical Average Price by Region (2018-2029)
- 4.2 North America Phospholipids in Pharmaceutical Consumption Value (2018-2029)
- 4.3 Europe Phospholipids in Pharmaceutical Consumption Value (2018-2029)
- 4.4 Asia-Pacific Phospholipids in Pharmaceutical Consumption Value (2018-2029)
- 4.5 South America Phospholipids in Pharmaceutical Consumption Value (2018-2029)
- 4.6 Middle East and Africa Phospholipids in Pharmaceutical Consumption Value (2018-2029)
5 Market Segment by Source
- 5.1 Global Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 5.2 Global Phospholipids in Pharmaceutical Consumption Value by Source (2018-2029)
- 5.3 Global Phospholipids in Pharmaceutical Average Price by Source (2018-2029)
6 Market Segment by Application
- 6.1 Global Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 6.2 Global Phospholipids in Pharmaceutical Consumption Value by Application (2018-2029)
- 6.3 Global Phospholipids in Pharmaceutical Average Price by Application (2018-2029)
7 North America
- 7.1 North America Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 7.2 North America Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 7.3 North America Phospholipids in Pharmaceutical Market Size by Country
- 7.3.1 North America Phospholipids in Pharmaceutical Sales Quantity by Country (2018-2029)
- 7.3.2 North America Phospholipids in Pharmaceutical Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 8.2 Europe Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 8.3 Europe Phospholipids in Pharmaceutical Market Size by Country
- 8.3.1 Europe Phospholipids in Pharmaceutical Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Phospholipids in Pharmaceutical Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 9.2 Asia-Pacific Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Phospholipids in Pharmaceutical Market Size by Region
- 9.3.1 Asia-Pacific Phospholipids in Pharmaceutical Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Phospholipids in Pharmaceutical Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 10.2 South America Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 10.3 South America Phospholipids in Pharmaceutical Market Size by Country
- 10.3.1 South America Phospholipids in Pharmaceutical Sales Quantity by Country (2018-2029)
- 10.3.2 South America Phospholipids in Pharmaceutical Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Phospholipids in Pharmaceutical Sales Quantity by Source (2018-2029)
- 11.2 Middle East & Africa Phospholipids in Pharmaceutical Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Phospholipids in Pharmaceutical Market Size by Country
- 11.3.1 Middle East & Africa Phospholipids in Pharmaceutical Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Phospholipids in Pharmaceutical Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Phospholipids in Pharmaceutical Market Drivers
- 12.2 Phospholipids in Pharmaceutical Market Restraints
- 12.3 Phospholipids in Pharmaceutical Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Phospholipids in Pharmaceutical and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Phospholipids in Pharmaceutical
- 13.3 Phospholipids in Pharmaceutical Production Process
- 13.4 Phospholipids in Pharmaceutical Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Phospholipids in Pharmaceutical Typical Distributors
- 14.3 Phospholipids in Pharmaceutical Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Phospholipids in Pharmaceutical. Industry analysis & Market Report on Phospholipids in Pharmaceutical is a syndicated market report, published as Global Phospholipids in Pharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Phospholipids in Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
